Blood–brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis

Vos, Catharina M.P., Geurts, Jeroen J.G., Montagne, Lisette, van Haastert, Elise S., Bö, Lars, van der Valk, Paul, Barkhof, Frederik, de Vries, Helga E.·2005·Neurobiology of Disease
DOI 10.1016/j.nbd.2005.06.012

Cited by (188)

Items 101–188 of 188

  1. BMP receptor blockade overcomes extrinsic inhibition of remyelination and restores neurovascular homeostasis
    Mark A. Petersen, Reshmi Tognatta, Anke Meyer‐Franke, Eric A. Bushong, Andrew S. Mendiola, Zhaoqi Yan, Abinaya Muthusamy, Mario Merlini, Rosa Meza-Acevedo, Belinda Cabriga et al. · 2021 · Brain
  2. Brown rats on farmland
    David Whyte Macdonald, Manuel Berdoy, Joanne P. Webster · 2015 · Oxford University Press eBooks
  3. Brain Barriers and Multiple Sclerosis: Novel Treatment Approaches from a Brain Barriers Perspective
    Hideaki Nishihara, Britta Engelhardt · 2020 · Handbook of experimental pharmacology
  4. Swiss Cheese Striatum
    Melinda S. Burnett, Robert J. Witte, J. Eric Ahlskog · 2014 · JAMA Neurology
  5. Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study
    Kenneth Wengler, Jason Ha, Olga Syritsyna, Lev Bangiyev, Patricia Katherine Coyle, Timothy Q. Duong, Mark E. Schweitzer, Xiang He · 2020 · Magnetic Resonance Imaging
  6. Blood‐brain barrier water exchange measurements using FEXI: Impact of modeling paradigm and relaxation time effects
    Elizabeth Powell, Yolanda Ohene, Marco Battiston, Ben Dickie, Laura M. Parkes, Geoff J.M. Parker · 2023 · Magnetic Resonance in Medicine
  7. Current concepts in the neuropathology and pathogenesis of multiple sclerosis.
    G. R. Wayne Moore · 2010 · The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  8. Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse
    José Antonio Serrano Acuña, Milagros Hidalgo de la Cruz, Alberto Lozano Ros, Saskia Prasca, María Luisa Martínez Ginés, Clara Dionisia de Andrés Frutos · 2017 · Multiple Sclerosis and Related Disorders
  9. Endothelial dysfunction in neurodegenerative disease: Is endothelial inflammation an overlooked druggable target?
    Megan Ritson, Caroline P.D. Wheeler-Jones, Helen B. Stolp · 2024 · Journal of Neuroimmunology
  10. Highly selective artificial gel antibodies for detection and quantification of biomarkers in clinical samples. II. Albumin in body fluids of patients with neurological disorders
    Nasim Ghasemzadeh, Fred Nyberg, Stellan Hjertén · 2008 · Journal of Separation Science
  11. Vascular damage in the central nervous system: a multifaceted role for vascular-derived TGF-β
    Kristina Beck, Kristina Schachtrup · 2011 · Cell and Tissue Research
  12. Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases
    Tingting Wen, Zhaohui Zhang · 2023 · Frontiers in Neuroscience
  13. Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis
    Norah G. Verbout, Xiaolin Yu, Laura D. Healy, Kevin G. Phillips, Erik I. Tucker, András Gruber, Owen J. T. McCarty, Halina Offner · 2014 · Metabolic Brain Disease
  14. Activation of the Coagulation Cascade as a Universal Danger Sign
    Элеонора Александровна Старикова, J. T. Mammedova, Artem Rubinstein, Sokolov Av, Igor Vladimirovich Kudryavtsev · 2025 · Current Issues in Molecular Biology
  15. Vascular and non‐vascular contributors to memory reduction during traumatic brain injury
    Mariam Charkviani, Nino Muradashvili, David G. Lominadze · 2019 · European Journal of Neuroscience
  16. Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire
    Jens O. Watzlawik, Bharath Wootla, Meghan M. Painter, Arthur E. Warrington, Moses Rodriguez · 2013 · Expert Review of Neurotherapeutics
  17. Using MS induced pluripotent stem cells to investigate MS aetiology
    Alastair J. Fortune, Jessica L. Fletcher, Nicholas B. Blackburn, Kaylene M. Young · 2022 · Multiple Sclerosis and Related Disorders
  18. Vascular Effects on Cerebrovascular Permeability and Neurodegeneration
    N. Sulimai, Jason Brown, D. Lominadze · 2023 · Biomolecules
  19. Hyperfibrinogenemia-mediated astrocyte activation
    Vincent D. Clark, Ailey Layson, Mariam Charkviani, Nino Muradashvili, David G. Lominadze · 2018 · Brain Research
  20. Characterization of blood–brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis
    Luisa Bell, Tobias Koeniger, Sabine Tacke, Stefanie Küerten · 2019 · Histochemistry and Cell Biology
  21. Weekly multimodal MRI follow‐up of two multiple sclerosis active lesions presenting a transient decrease in ADC
    Salem Hannoun, Jean‐Amédée Roch, Françoise Durand‐Dubief, Sandra Vukusic, Dominique Sappey‐Marinier, Charles R.G. Guttmann, François Cotton · 2015 · Brain and Behavior
  22. Effects of fibrinogen synthesis inhibition on vascular cognitive impairment during traumatic brain injury in mice
    Nino Muradashvili, Mariam Charkviani, Nurul Sulimai, Neetu Tyagi, Jeff R. Crosby, David G. Lominadze · 2020 · Brain Research
  23. Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging
    Alexandra Lipka, Eva Niess, Assunta Dal‐Bianco, Gilbert J. Hangel, Paulus Stefan Rommer, Bernhard Strasser, Stanislav Motyka, Lukas Hingerl, Thomas Berger, Petra Hnilicová et al. · 2022 · Investigative Radiology
  24. Diffusely Abnormal White Matter, T2 Burden of Disease, and Brain Volume in Relapsing‐Remitting Multiple Sclerosis
    Alexandra Talia Vertinsky, David K.B. Li, Irene M. Vavasour, Vladislav Miropolsky, Guojun Zhao, Yinshan Zhao, Andrew Riddehough, George R. Wayne Moore, Anthony L. Traboulsee, Cornelia Laule · 2018 · Journal of Neuroimaging
  25. Treating brain diseases using systemic parenterally-administered protein therapeutics: Dysfunction of the brain barriers and potential strategies
    Ahlem Zaghmi, Janelle Drouin‐Ouellet, Davide Brambilla, Marc Andre Gauthier · 2020 · Biomaterials
  26. Thrombin generation and activity in multiple sclerosis
    Kelley R. Jordan, Iván Parra‐Izquierdo, András Gruber, Joseph James Shatzel, Peter T. Pham, Larry S. Sherman, Owen J. T. McCarty, Norah G. Verbout · 2021 · Metabolic Brain Disease
  27. Structure and function of the perivascular fluid compartment and vertebral venous plexus: Illumining a novel theory on mechanisms underlying the pathogenesis of Alzheimer's, cerebral small vessel, and neurodegenerative diseases
    Michael George Zaki Ghali, Vitaliy Marchenko, Mahmut Gazi Yasargil, George Zaki Ghali · 2020 · Neurobiology of Disease
  28. Targeting the brain lesions using peptides: A review focused on the possibility of targeted drug delivery to multiple sclerosis lesions
    Atefeh Rayatpour, Mohammad Javan · 2021 · Pharmacological Research
  29. The Effects of Fibrinogen’s Interactions with Its Neuronal Receptors, Intercellular Adhesion Molecule-1 and Cellular Prion Protein
    Nurul Sulimai, Jason D. Brown, David G. Lominadze · 2021 · Biomolecules
  30. Fibrinogen: A potential biomarker for predicting disease severity in multiple sclerosis.
    Usman Ahmad, Jette Lautrup Frederiksen · 2020 · Multiple Sclerosis and Related Disorders
  31. Hemostatic factors in the pathogenesis of neuroinflammation in multiple sclerosis
    Gianmarco Abbadessa, Luigi Lavorgna, Constantina A. Treaba, Simona Bonavita, Caterina Mainero · 2021 · Multiple Sclerosis Journal
  32. Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    C. Bolton, Paul Smith · 2015 · CNS & Neurological Disorders - Drug Targets
  33. Fibrinogen-cellular prion protein complex formation on astrocytes
    Mariam Charkviani, Nino Muradashvili, Nurul Sulimai, David G. Lominadze · 2020 · Journal of Neurophysiology
  34. A potential role for CD8+ T-cells as regulators of CNS vascular permeability
    Georgette L. Suidan, Istvan Pirko, Aaron J. Johnson · 2006 · Neurological Research
  35. Quantitative T1 mapping detects blood–brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions
    Graziella Donatelli, Paolo Cipriano Cecchi, Gianmichele Migaleddu, Matteo Cencini, Paolo Frumento, Claudio D’Amelio, Luca Peretti, Guido Buonincontri, Livia Pasquali, Michela Tosetti et al. · 2023 · NeuroImage Clinical
  36. Fibrin-targeting molecular MRI in inflammatory CNS disorders
    Johannes Lohmeier, Rafaela V. Silva, Anna Tietze, Matthias Taupitz, Takaaki Kaneko, Harald Prüß, Friedemann Paul, Carmen Infante‐Duarte, Bernd Hamm, Peter D. Caravan et al. · 2022 · European Journal of Nuclear Medicine and Molecular Imaging
  37. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping
    Seongjin Choi, Margaret Spini, Jun Hua, Daniel M. Harrison · 2021 · PLoS ONE
  38. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing–Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance
    Efrosini Z. Papadaki, Vasileios C. Mastorodemos, Τheodora Panou, Styliani Pouli, Eirini C. Spyridaki, Eleftherios Kavroulakis, Georgios Kalaitzakis, Thomas G. Maris, Panagiotis G. Simos · 2021 · Journal of Magnetic Resonance Imaging
  39. Heterogeneity of White Matter Hyperintensities in Alzheimer's Disease: Post-Mortem Quantitative MRI and Neuropathology
    Alida A. Gouw, Alexandra Seewann, Hugo Vrenken, Wiesje M. van der Flier, Annemieke J.M. Rozemüller, Frederik Barkhof, Philip Scheltens, Jeroen J.G. Geurts · 2009 · The Neuroradiology Journal
  40. Blood–brain barrier water exchange measurements using contrast‐enhanced ASL
    Elizabeth Powell, Ben Dickie, Yolanda Ohene, Mark Peter Maskery, Geoff J.M. Parker, Laura M. Parkes · 2023 · NMR in Biomedicine
  41. How lung injury and therapeutic oxygen could alter white matter development
    Robert W. Dettman, Maria L.V. Dizon · 2021 · Journal of Neuroscience Research
  42. Significance of Virchow-Robin Spaces in Patients Newly Diagnosed with Multiple Sclerosis: A Case-Control Study in an Arab Population
    Osama Al‐Saeed, Reji Philip Athyal, Mohammed Taher Ismail, Mehraj Sheikh · 2012 · Medical Principles and Practice
  43. Multiple sclerosis and genetic polymorphisms in fibrinogen-mediated hemostatic pathways: a case–control study
    Gianmarco Abbadessa, Giuseppina Miele, Andrea Di Pietro, Maddalena Sparaco, Raffaele Palladino, Ignazio Armetta, Giovanna D’Elia, Francesca Trojsi, Elisabetta Signoriello, Giacomo Lus et al. · 2021 · Neurological Sciences
  44. The role of laquinimod in modulation of the immune response in relapsing–remitting multiple sclerosis: Lessons from gene expression signatures
    Rina Zilkha‐Falb, Michael Gurevich, Liat Hayardeny, Anat Achiron · 2015 · Journal of Neuroimmunology
  45. Th1 ‐ CD11c + B Cell Axis Associated with Response to Plasmapheresis in Multiple Sclerosis
    Kimitoshi Kimura, Youwei Lin, Hiromi Yamaguchi, Wakiro Sato, Daiki Takewaki, Misako Minote, Yoshimitsu Doi, Tomoko Okamoto, Ryōsuke Takahashi, Takayuki Kondo et al. · 2021 · Annals of Neurology
  46. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels
    Irene M. Vavasour, P. Becquart, Jasmine Gill, Guojun Zhao, J.T. Yik, Anthony L. Traboulsee, Robert L. Carruthers, Shannon Kolind, Alice J. Schabas, Ana‐Luiza Sayao et al. · 2021 · Multiple Sclerosis and Related Disorders
  47. Detection of diffusely abnormal white matter in multiple sclerosis on multiparametric brain MRI using semi-supervised deep learning
    Benjamin C. Musall, Refaat E. Gabr, Yanyu Yang, Arash Kamali, John A. Lincoln, Michael A. Jacobs, Vi Ly, Xi Luo, Jerry S. Wolinsky, Ponnada A. Narayana et al. · 2024 · Scientific Reports
  48. Immunomodulatory medicines for multiple sclerosis: Progress and prospects
    Alan M. Palmer · 2011 · Drug Development Research
  49. Long-term hemodialysis may affect enlarged perivascular spaces in maintenance hemodialysis patients: evidence from a pilot MRI study
    Hao Wang, Xue Han, Mingan Li, Zhenghan Yang, Wenhu Liu, Zhenchang Wang · 2021 · Quantitative Imaging in Medicine and Surgery
  50. Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination
    Gianmarco Abbadessa, Caterina Mainero, Simona Bonavita · 2022 · Clinical Pharmacology & Therapeutics
  51. Blood-Brain Barrier Dysfunction in the Detrimental Brain Function
    Alejandro González‐Candia, Nicole K. Rogers, Rodrigo L. Castillo · 2021 · IntechOpen eBooks
  52. Structure and Pathology of the Blood–Brain Barrier
    Sukriti Nag · 2007 · Springer eBooks
  53. Development of a humanized anti-fibrin monoclonal antibody for the treatment of neuroinflammatory and retinal diseases
    Aaron B. Kantor, Mathias Rickert, Hank Cheng, Kenneth Flanagan, Vasudha Salgotra, Anjana Suppahia, Jae Kyu Ryu, Paul Widboom, Joseph R. Warfield, Katerina Akassoglou et al. · 2025 · Journal of Neuroinflammation
  54. Age and Maturation Stage Linked Consequences of Fibrinogen on Human Oligodendroglia
    Gabriela J. Blaszczyk, Chao Weng, Abdulshakour Mohammadnia, Qiao‐Ling Cui, Arianna Giurleo, Adam M.R. Groh, Chloe Plouffe, Julien Sirois, Valerio E. C. Piscopo, Moein Yaqubi et al. · 2026 · Journal of Neuroscience Research
  55. Report on the Myomatrix Conference April 22–24, 2012, University of Nevada, Reno, Nevada, USA
    Anne Rutkowski, Carsten G. Bönnemann, S. Brown, Sólveig Þorsteinsdóttir, Janice A. Dominov, Markus A. Rüegg, Michelle L. Matter, Denis C. Guttridge, Rachelle H. Crosbie, Gabrielle Kardon et al. · 2012 · Neuromuscular Disorders
  56. Clinical trial methodology
    Jeffrey A. Cohen, Richard A. Rudick · 2011 · Cambridge University Press eBooks
  57. Neurovascular and Immuno-Imaging: From Mechanisms to Therapies. Proceedings of the Inaugural Symposium
    Katerina Akassoglou, Dritan Agalliu, Christopher J. Chang, Dimitrios Davalos, Jaime Grutzendler, Elizabeth M. C. Hillman, Baljit S. Khakh, David Kleinfeld, Dorian B. McGavern, Sarah J. Nelson et al. · 2016 · Frontiers in Neuroscience
  58. Fibrinogen and/or Fibrin as a Cause of Neuroinflammation.
    Nurul Sulimai, David G. Lominadze · 2021 · PubMed
  59. The blood brain barrier
    Cassidy Werner, Mansour Mathkour, Richard Shane Tubbs · 2022 · Elsevier eBooks
  60. Barriers of the CNS transfer rate dynamics in patients with vascular cognitive impairment and dementia
    Saeid Taheri, Jill Prestopnik, Gary A. Rosenberg · 2024 · Frontiers in Aging Neuroscience
  61. Imaging Microglia in the Central Nervous System: Past, Present and Future
    Dimitrios Davalos, Katerina Akassoglou · 2007 · Springer eBooks
  62. Impaired neurovascular-glymphatic functional association in chronic insomnia: Evidence from multimodal BOLD and DTI imaging
    Ya‐Qi Wen, Panpan Chen, Zhiyan Huang, Jiechai Lin, Xinxin Wang, Shuohua Wu, Shuohua Wu, Zhihong Zhao, Xiaolei Zhang, Yan Lin et al. · 2025 · Sleep Medicine
  63. An evaluation of perivascular space burden and contrast enhancement on 7T MRI in multiple sclerosis
    Yuxin Zeng, Austin Bertrand, Jiachen Zhuo, Daniel M. Harrison · 2025 · Multiple Sclerosis and Related Disorders
  64. Studying the blood–brain barrier will provide new insights into neurodegeneration – Yes
    Wouter W. Kamphuis, Helga E. de Vries · 2018 · Multiple Sclerosis Journal
  65. The Complex and Integral Roles of Pericytes Within the Neurovascular Unit in Health and Disease
    Brad A. Sutherland · 2021 · Stem cell biology and regenerative medicine
  66. Histopatholological Findings in a Fatal Case of Rinkhals Envenomation
    Jacob Joseph Moar, Lawrence N. Hill, Michael Stewart · 2016 · American Journal of Forensic Medicine & Pathology
  67. Central nervous system diseases associated with blood brain barrier breakdown - A Comprehensive update of existing literature
    Rajib Dutta · 2020 · Journal of Neuroscience and Neurological Disorders
  68. A quantitative measure of choroid plexus contrast enhancement strongly relates to markers of diffuse brain tissue injury in multiple sclerosis
    Sneha Senthil, Ian Tagge, Dumitru Fetco, Cheng Hsun Hsieh, Haz-Edine Assemlal, Zahra Karimaghaloo, Emily Fetco, George R. Wayne Moore, Douglas Lorne Arnold, David A. Rudko et al. · 2025 · medRxiv
  69. Autoimmune Processes in the Central Nervous System
    C. Jane Welsh, Colin R. Young · 2007 · Springer eBooks
  70. Interaction of brain endothelial cells with T cells: implications for progression and therapeutic strategies of multiple sclerosis
    Yan Zhao, Dongqi Zhu · 2026 · Frontiers in Neurology
  71. [Results of congenital cataract surgery using 2,2 microincision in children before the age of 5 years].
    Ines Malek, A. Chebbi, Imene Zghal, Firas Hachicha, O. Soumaya, C. Boujemaa, H. Bouguila, Leïla Nacef, Saida Ayed · 2013 · PubMed
  72. Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis
    Norah G. Verbout, Weiping Su, Peter T. Pham, Kelley R. Jordan, Tia C. L. Kohs, Erik I. Tucker, Owen J. T. McCarty, Larry S. Sherman · 2023 · American Journal of Physiology-Cell Physiology
  73. The Efficacy of Statins in Treating Relapse-Remission Multiple Sclerosis
    Todd E. Erickson · 2010 · CommonKnowledge Research Repository (Pacific University Oregon)
  74. Multiple Sclerosis: Impact on Functioning of the Blood–Brain Barrier
    Mark Ronald Mizee, Gijs Kooij, Helga E. de Vries · 2014 · Springer eBooks
  75. Measures of acute and chronic lesions visualized by conventional magnetic resonance imaging
    Jack H. Simon, Jerry S. Wolinsky · 2011 · Cambridge University Press eBooks
  76. Role of oligodendrocyte precursor cells in myelination and remyelination: recent advance
    Xiaojing Lin, Tingbao Zhao, Shaojun Liu · 2011 · Academic Journal of Second Military Medical University
  77. Extended perfusion protocol for MS lesion quantification
    Eleftherios Kontopodis, Kostas Marias A, Georgios C. Manikis, Katerina Nikiforaki, Maria Venianaki, Thomas G. Maris, Vasileios C. Mastorodemos, Georgios Z. Papadakis, Efrosini Z. Papadaki · 2020 · Open Medicine
  78. Gadolinium-based imaging of the blood brain barrier and brain waste clearance pathways
    2023 · Advances in magnetic resonance technology and applications
  79. E-WE thrombin, a protein C activator, reduces disease severity and spinal cord inflammation in relapsing-remitting murine experimental autoimmune encephalomyelitis
    Norah G. Verbout, Weiping Su, Peter T. Pham, Kelley R. Jordan, Tia C. L. Kohs, Erik I. Tucker, Owen J. T. McCarty, Larry S. Sherman · 2023 · Research Square
  80. Immunohistochemical evaluation of fibrin/fibrinogen, d-dimers, and intravascular thrombosis in brains of dogs with meningoencephalitis of unknown origin
    M. Raposo, Cristian de la Fuente, Martí Batlle Pumarola, José Ríos, Sònia Añor · 2023 · The Veterinary Journal
  81. Microglial glutathione and glutamate: regulation mechanisms
    Victoria A. H. Fry · 2009 · UCL Discovery (University College London)
  82. Additional file 2 of Inflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis
    Cathrin Elly Hansen, Alwin Kamermans, Kevin Mol, Kristina Berve, Carla Rodriguez-Mogeda, Wing Ka Fung, Bert van het Hof, Ruud D. Fontijn, Susanne M. A. van der Pol, Laura Michalick et al. · 2024 · Figshare
  83. Additional file 1 of Inflammation-induced TRPV4 channels exacerbate blood–brain barrier dysfunction in multiple sclerosis
    Cathrin Elly Hansen, Alwin Kamermans, Kevin Mol, Kristina Berve, Carla Rodriguez-Mogeda, Wing Ka Fung, Bert van het Hof, Ruud D. Fontijn, Susanne M. A. van der Pol, Laura Michalick et al. · 2024 · Figshare
  84. Quantitative Choroid Plexus Gadolinium Enhancement Is Related to Diffuse Brain Tissue Injury in Multiple Sclerosis
    Sneha Senthil, Ian Tagge, Dumitru Fetco, Cheng Hsun Hsieh, Haz-Edine Assemlal, Zahra Karimaghaloo, Emily Fetco, G. R. Wayne Moore, Douglas Lorne Arnold, David A. Rudko et al. · 2026 · Journal of Neuroimaging
  85. Macrophage activation profiles of multiple sclerosis patients
    Jennifer Fransson · 2019 · theses.fr (ABES)
  86. Associations between Paramagnetic Rim Lesions and Gadolinium Contrast Permeability of Perivascular Spaces in Patients with MS: A T1 Mapping Study
    Hye Hyeon Moon, Eunseon Jeong, Muhannad Alanazi, Yoonho Nam, Sugil Kim, Da-Young Seo, Eun-Jae Lee, Ho Sung Kim, Yangsean Choi · 2026 · American Journal of Neuroradiology
  87. Heightened respiratory brain pulsations indicate fluid dynamic dysfunction in early multiple sclerosis
    Jere Haverinen, Mervi Ryytty, Harri Rusanen, Johanna Krüger, Mika Henrik Martikainen, Janne Kananen, Lauri Raitamaa, Niko Huotari, Matti Järvelä, Johanna Tuunanen et al. · 2026 · Journal of Cerebral Blood Flow & Metabolism
  88. Relating perivascular imaging measures to longitudinal lesion evolution and chronic inflammation in multiple sclerosis
    Ashley Tranquille, Niels Bergsland, Jack A. Reeves, Alex Bartnik, Bianca Weinstock‐Guttman, Svetlana Primma Eckert, David W. Hojnacki, Michael G. Dwyer, Robert Zivadinov · 2026 · Multiple Sclerosis and Related Disorders